Day: February 9, 2022

RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter and full year 2021 financial results Wednesday, February 23, 2022. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 877-303-8027 for domestic callers and 760-536-5165 for international callers and using conference ID # 6365545. A live webcast of the call and any slides will be available online at the investors section of the company website at www.biocryst.com. A telephone replay of the call will be available by dialing 855-859-2056 for domestic callers or 404-537-3406 for international callers and entering the conference...

Ethics Committee Approval is Final Step Prior to Enrollment of Claritas’ Phase 1 Clinical Study of R-107 SAN FRANCISCO, CA and TORONTO, ON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today announced that the Australian Human Research Ethics Committee (HREC) will meet on February 16th to review the submission made by the Company for the Phase 1 clinical study of R-107. The Company expects to receive comments or approval from the HREC by February 18th. HREC approval is the final regulatory step prior to initiation of the study. Claritas will begin enrollment in the study immediately following receipt of HREC approval. Phase 1 Study Overview The Phase 1 study will be a double-blind, single-center, single ascending dose escalation...

NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) — Hudson Capital Inc. (NASDAQ: HUSN) (Hudson Capital) announced that Freight App, Inc. (Fr8App), a North American transportation logistics technology platform company focused on US-Mexico cross-border shipping with which Hudson Capital has entered into a merger agreement, projects 2022 revenue to be no less than $40 million, compared to preliminary 2021 revenue of approximately $21.5 million. “Fr8App continues to gain momentum as 2022 revenue is projected to grow at least 86% and more than four times, compared to 2021 and 2020, respectively,” commented Javier Selgas, CEO of Fr8App. “More importantly, we continue to invest in our technology and are capturing early returns from our new product offerings. For example, last week, we launched Fr8PrivateFleet, which already has begun to receive...

Australia is one of the most coveted and valuable regulated betting markets in the world TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), an internationally regulated sports betting and media company, today announced the approval of its sports bookmaker license by the Northern Territory Racing Commission (Australia) (the “NTRC”) pursuant to the Racing and Betting Act 1983 (NT), which allows the Company to legally operate throughout the whole of the country. Australia is Rivalry’s first fully regulated market, representing a key milestone in the Company’s growth strategy. “Expansion into regulated markets across the globe is a key part of our growth strategy, and we couldn’t be more thrilled to officially receive our license for Australia,” said Steven Salz,...

REGINA, SASKATCHEWAN & TORONTO, ONTARIO, Feb. 09, 2022 (GLOBE NEWSWIRE) — SSC Security Services Corp. (“SSC”) (TSXV: SECU) (OTCQX: SECUF), is pleased to announce that it has entered into a definitive arrangement agreement (“Arrangement Agreement”) to acquire Avante Logixx Inc. (“Avante”) (TSXV: XX) (OTC: ALXXF), a Toronto-based provider of full service, elite security solutions for high-net-worth residential customers, as well as premium security protection for leading enterprise and commercial clients across Canada, through its operating subsidiaries Avante Security Inc. (“ASI”) and Logixx Security Inc. (“LSI”), respectively. Pursuant to the terms of the Arrangement Agreement, SSC has agreed to acquire all of the issued and outstanding common shares of Avante (“Avante Shares”) by way of a statutory plan of arrangement (“Plan...

Company to host conference call and webcast at 3 p.m. PT on Tuesday, February 15, 2022 CARLSBAD, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and associated diseases (i.e. COVID-19), today announced that a virtual investor event will be hosted by the company’s management team following the presentation of clinical data from the ongoing PBI-0451 Phase 1 trial at the 29th Conference On Retroviruses And Opportunistic Infections (CROI) 2022. The conference call and webcast will take place on Tuesday, February 15 at 3:00 p.m. PT / 6:00 p.m. ET. Individuals interested in listening to the event may do so by dialing...

BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral direct acting therapeutics for severe viral diseases, today announced that Jean-Pierre Sommadossi, Ph.D., Chief Executive Officer and Founder of Atea Pharmaceuticals together with other members of the Atea management team, will participate in a fireside chat and provide a business update at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. ET. A live webcast of the presentation will be available here and on the Company’s website at www.ateapharma.com. A replay of the webcast will be available for 90 days following the presentation. About Atea Pharmaceuticals Atea Pharmaceuticals is a clinical stage...

Figure 1Map depicting 2021 Rock Sampling LocationsFigure 2Maps comparing geological and structural similarities between the Keno Hill and Plata silver districtsTORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (OTCQB: HBEIF) (“Honey Badger” or the “Company”) is pleased to announce the third batch of channel, chip and rock sample analyses from the 2021 field program at its 100%-owned, 5,690 hectare Plata Silver Property (“Plata”) located in east-central Yukon. Highlights of silver, lead and zinc assays from trench and chip sampling at the P2 Zone are listed below:4,300 g/t silver, 46.4% lead and 22% zinc over 1.0 metre 1,775 g/t silver, 48.78% lead and 13.35% zinc over 1.2 metres 1,140 g/t silver, 24.16% lead and 16.41% zinc over 2.49 metres 12,806 g/t silver, 76.08%...